As the most reliable and balanced news aggregation service on the internet, DML News App offers the following information published by CBSNEWS.COM:
With no proven treatment or vaccine for coronavirus, the scientific community has turned to a promising near-term solution with the use of antibody drugs. Regeneron is one of several biotech companies developing such an approach. Regeneron President and Chief Scientific Officer Dr. George Yancopoulos sat down with “CBS Evening News” host Norah O’Donnell to discuss the company’s efforts to combat the pandemic.
Basically, there are natural signals in the body that drive beneficial immune and inflammatory responses. The problem is, oftentimes these immune and inflammatory responses can become excessive, and they can create more damage than good. The hope is, by using this antibody that specifically blocks this one inflammatory pathway, it can actually benefit the inflammation that’s seen in lungs that’s causing people to have the difficulties breathing, and eventually succumbing to this tragic disease.
The article goes on to state the following:
So, some clever scientist in China decided to try it and they reported that yes, it looked like it might be benefiting the inflammation that you get in the lungs in this disease and patients might be getting better. Those studies were uncontrolled anecdotal studies. We initiated a controlled study to see whether or not this really can make a difference for patients.
To get more information about this article, please visit CBSNEWS.COM.